Physical safety monitoring

The manuals converge on close, continuous monitoring of participants during dosing sessions, with repeated attention to vital signs, physical stability, and signs of acute distress. Across MDMA, psilocybin, ayahuasca, and ibogaine protocols, the sources repeatedly describe observation for nausea, vomiting, dizziness, agitation, panic, confusion, psychosis, or other adverse reactions, alongside practical support such as helping with movement, hydration, and safe discharge. They also converge on the idea that safety takes priority over the session itself. Several manuals explicitly mention escalation to a physician, medical monitor, or emergency support when symptoms worsen, and some add readiness measures such as emergency support availability, discharge criteria, or withholding supplemental dosing when safety concerns arise. Sources differ mainly in the specific monitoring emphasis. MDMA manuals place stronger weight on cardiovascular and thermoregulatory monitoring, hydration limits, and fall prevention, while psilocybin manuals more often stress constant observation, emotional and physical support, and remaining with the participant until acute effects subside. Ayahuasca protocols give more attention to nausea, vomiting, blood pressure, and post-acute vigilance, and ibogaine materials emphasise prolonged observation and repeated checks over a longer post-dose period.